Coveram 10/10 mg is a fixed-dose combination oral prescription medication formulated for the treatment of essential hypertension (high blood pressure) and stable coronary artery disease. It integrates two proven cardiovascular agents—Perindopril arginine (an Angiotensin-Converting Enzyme inhibitor) and Amlodipine besylate (a Calcium Channel Blocker)—into a single daily tablet.
This dual-therapy formulation is primarily indicated for adult patients whose blood pressure requires combination therapy, or for patients whose condition is already controlled with individual doses of perindopril 10 mg and amlodipine 10 mg taken simultaneously. By addressing distinct pathways of vascular resistance, Coveram assists in achieving and maintaining target blood pressure levels, thereby reducing overall cardiovascular risk.
Active Ingredients & Dual-Action Mechanism
Coveram 10/10 mg combines two active pharmaceutical ingredients that function synergistically to lower blood pressure and optimize myocardial oxygen supply:
Perindopril Arginine (10 mg per tablet): A long-acting ACE inhibitor (Angiotensin-Converting Enzyme inhibitor). It works by inhibiting the enzyme responsible for converting angiotensin I into angiotensin II, a potent endogenous vasoconstrictor. By suppressing angiotensin II levels, perindopril reduces peripheral arterial resistance, decreases aldosterone secretion, and promotes vasodilation.
Amlodipine Besylate (10 mg per tablet): A dihydropyridine calcium channel blocker (CCB). It inhibits the transmembrane influx of calcium ions into vascular smooth muscle cells and cardiac muscle cells. This relaxes arterial smooth muscle, dilates peripheral arterioles, and reduces total peripheral resistance (afterload) against which the heart pumps.
Synergistic Pharmacological Action
Arterial Relaxation and Vasodilation: While amlodipine relaxes vascular smooth muscle directly in the peripheral vessels, perindopril targets the hormonal pathway responsible for blood vessel constriction. Together, they provide comprehensive vascular relaxation.
Reduction of Cardiac Workload: By lowering peripheral vascular resistance, the heart requires less energy to circulate blood throughout the body, improving systemic perfusion while decreasing myocardial strain.
Complemented Metabolic Profile: The co-administration of an ACE inhibitor with a calcium channel blocker helps mitigate certain single-agent side effects, such as amlodipine-induced peripheral edema (ankle swelling), due to perindopril's balanced dilation of both arterial and venous beds.
Key Medical Indications & Clinical Benefits
Optimal Blood Pressure Control: Effectively lowers both systolic and diastolic blood pressure in patients needing dual-component therapy.
Cardiovascular Risk Reduction: Consistent blood pressure management significantly lowers long-term incidence of adverse cardiovascular events, including stroke, myocardial infarction (heart attack), and heart failure.
Management of Stable Coronary Artery Disease: Reduces the risk of cardiac events in patients with a history of coronary artery disease by improving blood flow through the coronary arteries.
Enhanced Therapy Compliance: Combining two first-line antihypertensive agents into a single once-daily tablet reduces pill burden and improves patient adherence to long-term treatment regimens.
Usage Instructions & Administration
Important: Coveram is a prescription-only medication. It must be administered strictly in accordance with the dosage and guidance prescribed by a licensed healthcare professional.
Standard Adult Dosing: The typical dosage is one tablet (10/10 mg) once daily.
Administration: Tablets should be taken orally, preferably in the morning before a meal, with a full glass of water. Taking the medication at the same time each day helps maintain consistent plasma concentrations.
Treatment Duration: Hypertension management is typically a long-term or lifelong therapy. Do not alter the dose or discontinue treatment abruptly without consulting your treating physician.
Missed Dose Protocol: If a dose is missed, take it as soon as remembered on the same day. If it is nearly time for the next scheduled dose, skip the missed tablet and resume the standard schedule. Never take a double dose to compensate for a forgotten tablet.
Safety Precautions, Warnings & Contraindications
Absolute Contraindications
Pregnancy and Breastfeeding: Coveram is strictly contraindicated during pregnancy, particularly during the second and third trimesters, as ACE inhibitors can cause serious fetal injury, oligohydramnios, and neonatal renal failure. It is also not recommended during lactation.
Hypersensitivity: Known hypersensitivity to perindopril, amlodipine, any other ACE inhibitor or dihydropyridine derivative, or any of the product's inactive excipients.
History of Angioedema: Patients with a history of angioedema (hereditary, idiopathic, or secondary to previous ACE inhibitor therapy).
Severe Renal or Hepatic Impairment: Severe renal artery stenosis, severe renal failure, severe liver impairment, or unstable hemodynamic conditions such as cardiogenic shock or severe aortic stenosis.
Concomitant Aliskiren Use: Simultaneous use with aliskiren-containing products in patients with diabetes mellitus or renal impairment (GFR less than 60 mL/min/1.73 m²).
Warnings and Precautions
Monitoring Parameters: Regular monitoring of blood pressure, serum electrolytes (especially potassium levels), and renal function (serum creatinine and blood urea nitrogen) is recommended throughout treatment.
Risk of Hypotension: Symptomatic hypotension may occur, particularly in volume-depleted or salt-depleted patients (e.g., those receiving high-dose diuretics or experiencing severe diarrhea/vomiting). Volume depletion should be corrected before starting therapy.
Drug Interactions: Caution is required when co-administering with potassium supplements, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs (NSAIDs), or immunosuppressants. Always inform your doctor of all concurrent medications.
Product Specifications & Storage
Dosage Form: Oral film-coated tablets.
Packaging: Bottle containing 30 tablets with a moisture-protective closure.
Storage Requirements: Store below 30°C (86°F) in the original container to protect from light and moisture. Keep the container tightly closed and out of reach of children.